Chronic obstructive pulmonary disease (COPD) plays a significant role in global morbidity
and mortality rates, typified by progressive airflow restriction and lingering respiratory …

There is an intense focus on the identification of novel biomarkers of chronic obstructive
pulmonary disease (COPD) to enhance clinical decisions in patients with stable disease and …

Health initiatives worldwide demand affordable point-of-care devices to aid in the reduction
of morbidity and mortality rates of high-incidence infectious and noncommunicable …

Background Although chronic inflammation, oxidative stress, airway remodeling, and
protease-antiprotease imbalance have been implicated in chronic obstructive pulmonary …

Background Due to shared symptoms, acute heart failure (AHF) is difficult to differentiate
from an acute exacerbation of COPD (AECOPD). This systematic review aimed to identify …

Objective Accurate biomarkers for evaluating mortality rates in patients with chronic
obstructive pulmonary disease (COPD) remain scarce. This study aimed to explore the …

Aim To explore the predictive value of lactate-to-albumin ratio (LAR) on 28-day mortality in
patients with exacerbation of chronic obstructive pulmonary disease (AECOPD) admitted to …

Chronic obstructive pulmonary disease (COPD) is a progressive lung dysfunction that can
be triggered by exposure to chemicals. This disease can be identified with spirometry, but …

Chronic inflammatory diseases (CIDs) are debilitating and potentially lethal illnesses that
affect a large proportion of the global population. Osteopathic manipulative treatment (OMT) …

Chronic obstructive pulmonary disease (COPD) is an inflammatory lung pathology
characterized by persistent airflow limitation and is the third leading cause of death globally …